CAD 0.03
(-14.29%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 9.1 Million CAD | -6.71% |
2022 | 9.75 Million CAD | -13.66% |
2021 | 11.3 Million CAD | -15.71% |
2020 | 13.4 Million CAD | 191.08% |
2019 | 4.6 Million CAD | 178.74% |
2018 | 1.65 Million CAD | 670.61% |
2017 | 214.43 Thousand CAD | 21442900.0% |
2016 | 1.00 CAD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q3 | 6.37 Million CAD | -28.59% |
2024 Q2 | 8.93 Million CAD | -0.32% |
2024 Q1 | 8.95 Million CAD | -1.57% |
2023 Q4 | 9.1 Million CAD | 14.48% |
2023 FY | 9.1 Million CAD | -6.71% |
2023 Q1 | 9.74 Million CAD | -0.08% |
2023 Q2 | 9.76 Million CAD | 0.16% |
2023 Q3 | 7.95 Million CAD | -18.57% |
2022 Q1 | 14.19 Million CAD | 25.57% |
2022 Q3 | 14.17 Million CAD | -0.18% |
2022 FY | 9.75 Million CAD | -13.66% |
2022 Q4 | 9.75 Million CAD | -31.15% |
2022 Q2 | 14.19 Million CAD | 0.04% |
2021 Q1 | 13.89 Million CAD | 3.64% |
2021 FY | 11.3 Million CAD | -15.71% |
2021 Q4 | 11.3 Million CAD | -23.02% |
2021 Q3 | 14.67 Million CAD | 1.59% |
2021 Q2 | 14.45 Million CAD | 4.0% |
2020 Q2 | 8.25 Million CAD | 40.46% |
2020 Q3 | 11.1 Million CAD | 34.61% |
2020 Q4 | 13.4 Million CAD | 20.7% |
2020 FY | 13.4 Million CAD | 191.08% |
2020 Q1 | 5.87 Million CAD | 27.55% |
2019 Q4 | 4.6 Million CAD | 76.56% |
2019 Q1 | 1.69 Million CAD | 2.57% |
2019 Q2 | 2.47 Million CAD | 45.8% |
2019 FY | 4.6 Million CAD | 178.74% |
2019 Q3 | 2.6 Million CAD | 5.57% |
2018 Q3 | 269.98 Thousand CAD | 7.18% |
2018 FY | 1.65 Million CAD | 670.61% |
2018 Q2 | 251.9 Thousand CAD | 1.29% |
2018 Q1 | 248.69 Thousand CAD | 15.98% |
2018 Q4 | 1.65 Million CAD | 512.05% |
2017 Q3 | 205.41 Thousand CAD | 20541600.0% |
2017 FY | 214.43 Thousand CAD | 21442900.0% |
2017 Q4 | 214.43 Thousand CAD | 4.39% |
2017 Q2 | 1.00 CAD | 0.0% |
2016 FY | 1.00 CAD | 0.0% |
2016 Q4 | 1.00 CAD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Aion Therapeutic Inc. | 210.67 Thousand CAD | -4220.602% |
Ayurcann Holdings Corp. | 14.85 Million CAD | 38.721% |
Blueberries Medical Corp. | 2.41 Million CAD | -276.647% |
The BC Bud Corporation | 632.06 Thousand CAD | -1340.087% |
BioNxt Solutions Inc. | 1.26 Million CAD | -618.098% |
CordovaCann Corp. | 10.26 Million CAD | 11.316% |
Christina Lake Cannabis Corp. | 15.96 Million CAD | 42.977% |
Captor Capital Corp. | 33.85 Million CAD | 73.113% |
City View Green Holdings Inc. | 3846.00 CAD | -236569.215% |
1CM Inc. | 34.01 Million CAD | 73.243% |
Global Hemp Group Inc. | 42.76 Thousand CAD | -21186.448% |
Greenway Greenhouse Cannabis Corporation | 33.08 Million CAD | 72.492% |
IM Cannabis Corp. | 48.81 Million CAD | 81.353% |
Lobe Sciences Ltd. | 2.29 Million CAD | -295.84% |
Maple Leaf Green World Inc. | 168.27 Thousand CAD | -5309.245% |
Mountain Valley MD Holdings Inc. | 8.96 Million CAD | -1.52% |
Nextleaf Solutions Ltd. | 8.53 Million CAD | -6.621% |
Ovation Science Inc. | 76.88 Thousand CAD | -11738.386% |
Pharmadrug Inc. | 1.45 Million CAD | -523.579% |
RAMM Pharma Corp. | 32.3 Million CAD | 71.82% |
RIV Capital Inc. | 1.74 Million CAD | -422.955% |
Revive Therapeutics Ltd. | 10.63 Million CAD | 14.419% |
Red White & Bloom Brands Inc. | 234.25 Million CAD | 96.114% |
SLANG Worldwide Inc. | 33.2 Million CAD | 72.586% |
1933 Industries Inc. | 18.01 Million CAD | 49.487% |
Red Light Holland Corp. | 24.08 Million CAD | 62.206% |
Top Strike Resources Corp. | 11.73 Million CAD | 22.436% |
Xebra Brands Ltd. | 379.36 Thousand CAD | -2299.332% |
Adastra Holdings Ltd. | 32.34 Million CAD | 71.857% |